Phase I Trials Current
| Study | Study description | Investigator | Study Coordinator |
|
Protocol C-035-456. (AERAS 456) |
Phase 1/11a Double-Blind , Randomized , Placebo-Controlled, Dose-Finding Study to Evaluate the Safety and Immunogenicity of AERAS-456 in HIV negative Adults with and without Latent Tuberculosis Infection. Age 18-50. | Angelique Luabaya. | Rachel Oelofse |
SATVI Worcester Site Office:
SATVI Project Office, University of Cape Town, Brewelskloof Hospital, Haarlem Street, WORCESTER, 6850.
Tel: +27 23 346 5400
Fax: +27 23 346 5406
Email: Field Site Manager
GPS coordinates -33.620455, 19.458576
Map to Worcester Field Office